Tower House Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $7.77M | Buy |
35,678
+1,219
| +4% | +$266K | 46.23% | 1 |
|
|
2022
Q3 | $6.78M | Sell |
34,459
-15,011
| -30% | -$2.95M | 27.97% | 3 |
|
|
2022
Q2 | $10.6M | Sell |
49,470
-5,530
| -10% | -$1.18M | 31.02% | 3 |
|
|
2022
Q1 | $15.6M | Sell |
55,000
-33,925
| -38% | -$9.63M | 27.22% | 3 |
|
|
2021
Q4 | $33.5M | Buy |
88,925
+686
| +0.8% | +$258K | 28.7% | 3 |
|
|
2021
Q3 | $36.4M | Sell |
88,239
-34,974
| -28% | -$14.4M | 20.66% | 3 |
|
|
2021
Q2 | $45.6M | Sell |
123,213
-34,028
| -22% | -$12.6M | 23.73% | 2 |
|
|
2021
Q1 | $45.6M | Sell |
157,241
-29,897
| -16% | -$8.67M | 22.18% | 2 |
|
|
2020
Q4 | $46.8M | Sell |
187,138
-22,862
| -11% | -$5.71M | 22.81% | 2 |
|
|
2020
Q3 | $47.6M | Sell |
210,000
-20,000
| -9% | -$4.53M | 25.47% | 2 |
|
|
2020
Q2 | $40.1M | Buy |
+230,000
| New | +$40.1M | 19.4% | 2 |
|